NewGenIvf Group Ltd — Form F-1
Filed August 20, 2026 · analyzed by the Registration Agent
F-1
— Neutral
significance 42/100
What the filing says
NewGenIvf Group Ltd (total assets ~$32.7M) is executing a best-efforts secondary offering of approximately $10.0M in Class A Ordinary Shares via placement agent Aegis Capital Corp, with an 8.0% placement commission. Separately, the company issued a $257,000 convertible promissory note to Vanquish Funding Group Inc. dated October 15, 2025, convertible at 75% of 10-day market price (25% discount), maturing July 30, 2026, at 10% interest, with provisions for up to $2.2M in additional tranches over 12 months. The note includes extensive default provisions, conversion mechanics, and liquidated damages if shares are not delivered timely.
Why this rating
Secondary offering of $10M (~31% of company assets) is material in scale, but structure is best-efforts non-binding, reducing certainty. Vanquish debt is modest ($257K, <1% of assets). Combined equity dilution and debt load are moderate relative to company size; neither transformational nor routine.
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.